Abbott says its HeartMate 3 LVAD is clinically proven to extend life by five years or more — but thousands of people in the U.S. still die of heart failure within a year. Kyree Miller, a 30-year-old college student, navigated seven long years of heart failure with the assistance of an Abbott HeartMate left ventricular […]
DeviceTalks
5 keys to Mike Mahoney and Boston Scientific’s success
Boston Scientific’s market capitalization has grown nearly 10 times larger since Mike Mahoney joined as CEO in 2011. He shared key insights about corporate strategy at DeviceTalks Boston in May. Boston Scientific is one of the bright spots as the medical device industry goes through a rough patch. It’s more expensive to run a business, […]
BD CEO Tom Polen discusses character revealed by COVID-19 crisis
“We couldn’t be more proud of how the team really showed our values,” BD CEO Tom Polen said during a keynote at DeviceTalks Boston. Tom Polen’s original “master plan” included medical school. While preparing for the MCAT out of undergrad, he instead joined a small startup based in California. The startup grew and BD (NYSE:BDX) […]
22 MedTech Innovator all-stars will pitch at DeviceTalks Boston
Nearly two dozen MedTech Innovator portfolio startups will pitch their technology to medtech industry innovators, executives and engineers at DeviceTalks Boston on May 10-11. The MedTech Innovator accelerator program picked the 22 all-stars from hundreds of applicants. The all-stars who will be featured over the two-day event at the Boston Convention and Exhibition Center are: […]
Opportunity awaits at DeviceTalks Boston
Medtech faces many challenges, but every challenge presents an opportunity — and DeviceTalks Boston will focus on making the best of them. Leaders like to say every challenge presents an opportunity. It sounds uplifting and offers the benefits of being at least partially true, in life and in medtech. It’s fair to say the medical […]
DeviceTalks Boston early-bird rate expires today
Today is the final opportunity to secure the early-bird rate to register for DeviceTalks Boston. The rate will jump from $395 to $695 where it will stay until the day of the May 10-11 conference, which will be held at the Boston Convention & Exhibition Center. DeviceTalks Boston promises to deliver two days of networking, […]
DeviceTalks Boston early-bird rate expires tomorrow
The early-bird registration discount for DeviceTalks Boston ends tomorrow, March 9. Register right away to save $300 off (43%) off the full price to attend the May 10-11 event at the Boston Convention & Exhibition Center. Discussions will focus on engineering new devices, materials and manufacturing, bringing products to market, and other challenges to medical […]
DeviceTalks Boston early bird pricing expires next week
Medical device professionals eager to expand their skillsets and build their brand have until March 9 to secure the early-bird rate to register for DeviceTalks Boston. The rate will jump from $395 to $695 where it will stay until the day of the May 10-11 conference, which will be held at the Boston Convention & […]
How these engineers make DeviceTalks Boston go!
We love engineers of all types — here are just a few you’ll meet at DeviceTalks Boston. We love engineers here at DeviceTalks. It’s obvious why. Engineers are the straw that stirs medtech’s drink (apologies to Reggie Jackson). Nothing happens — financing, manufacturing, approval, help for patients — without a well-conceived product. And engineers often […]
DeviceTalks Weekly: What’s your top story of 2022?
DeviceTalks Weekly is inviting listeners to record their personal picks for top medtech story of 2022. It’s easy! Step 1 — Make sure you’re on a device with a good microphone. Phones work great! Step 2 — Click here. This will open a new window. Step 3 — Open up by giving us you name, […]
How Johnson & Johnson is looking to lead the way in ablation
Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business. Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees. Over 25 years at Johnson & Johnson, […]
